跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMITRIPTYLINE SANDOZ amitriptyline hydrohloride 25mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
AMITRIPTYLINE SANDOZ amitriptyline hydrohloride 25mg tablet blister pack
Approved
STANDARD
AMITRIPTYLINE SANDOZ amitriptyline hydrohloride 25mg tablet blister pack
Ipca Pharma (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
1ddf0d3a120a4c9b
Company
Ipca Pharma (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
1ddf0d3a120a4c9b
Product Name
AMITRIPTYLINE SANDOZ amitriptyline hydrohloride 25mg tablet blister pack
Artg Id
432990
Artg Name
AMITRIPTYLINE SANDOZ amitriptyline hydrochloride 25mg tablet blister pack
Sponsor
Ipca Pharma (Australia) Pty Ltd
Company Detail Path
/organization/ipca-pharma-australia-pty-ltd
Artg Date
2024-05-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/604332b794a3127c8c14a7d6ed135e2f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
1ddf0d3a120a4c9b
Type
Standard
Back to TGA Approvals
